Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised in connection with the sale of Mark Bric to Sareq
Mandate

Vinge has advised in connection with the sale of Mark Bric to Sareq

October 15, 2024 M&A

Vinge has advised the sellers in connection with the sale of all shares in Mark Bric AB to Sareq AB. Mark Bric manufactures and sells high quality size markers to the global retail industry.

Vinge's team primarily consisted of Anders Strid, Anna Ståhlklo (project manager), Amelia Rihs (M&A), Hannah Mark (M&A), Anders Leissner (regulatory) and Amanda Stoltz (VDR). Censor M&A acted as financial advisor to the seller.

Related

Vinge has advised Verisure in connection with its IPO on Nasdaq Stockholm

 Vinge has advised Verisure plc (“Verisure”) in connection with its IPO on Nasdaq Stockholm. Following the publication of the prospectus on 29 September 2025, trading in Verisure’s shares commenced today, 8 October 2025.
October 08, 2025

Vinge has acted for Advania on the acquisition of smartvokat

smartvokat GmbH, a German-based consultancy specialising in digital transformation within the legal, risk, and compliance domains, will become part of Advania’s business unit Transformation & Automation.
October 08, 2025

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025